Colorectal liver metastases that survive radioembolization display features of aggressive tumor behavior
HPB · 2023
DOI: 10.1016/j.hpb.2023.06.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2023. Verfasst von Daan Andel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, University Medical Center Utrecht, Cancer Center, Utrecht, the Netherlands. Electronic address: D.S.H.Andel-3@umcutr…. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms, Embolization, Therapeutic, Yttrium Radioisotopes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Radiation lobectomy is a therapeutic approach that involves targeted radiation delivery to induce future liver remnant hypertrophy and tumor control. In patients with colorectal liver metastases, only 30-40% have complete tumor regression. The importance of tumor biology in treatment response remains elusive. METHODS: Patients with colorectal liver metastases who received radiation lobectomy were selected from surgical pathology files. Using a machine learning scoring protocol, pathological response was correlated to tumor absorbed dose and expression of markers of radioresistance Ki-67 (proliferation), CAIX (hypoxia), Olfm4 (cancer stem cells) and CD45 (leukocytes). RESULTS: No linear association was found between tumor dose and response (ρ 15%) of Olfm4 positive cancer stem cells (Fisher's exact test, P = 0.0037). Responding lesions (regression grade ≤2) were highly hypoxic compared to moderate and non-responding lesions (P = 0.011). Non-responsive lesions had more tumor-infiltrating leukocytes (3240 cells/mm2 versus 650 cells/mm2), although this difference was not significant (P = 0.08). CONCLUSION: The aggressive phenotype of a subset of surviving cancer cells emphasizes the importance of prompt resection after radiation lobectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology, University Medical Center Utrecht, Cancer Center, Utrecht, the Netherlands. Electronic address: D.S.H.Andel-3@umcutrecht.nl.
- Department of Surgical Oncology, University Medical Center Utrecht, Cancer Center, Utrecht, the Netherlands.
- Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Cancer Center, Utrecht, the Netherlands.
- Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- Department of Surgical Oncology, University Medical Center Utrecht, Cancer Center, Utrecht, the Netherlands. Electronic address: I.H.M.BorelRinkes@umcutrecht.nl.
Zitieren
APA
Andel, D., Hagendoorn, J., Alsultan, A. A., Lacle, M. M., Smits, M. L. J., Braat, A. J. A. T., Kranenburg, O., Lam, M. G. E. H., & Borel Rinkes, I. H. M. (2023). Colorectal liver metastases that survive radioembolization display features of aggressive tumor behavior. HPB. https://doi.org/10.1016/j.hpb.2023.06.011
Vancouver
Andel D, Hagendoorn J, Alsultan AA, Lacle MM, Smits MLJ, Braat AJAT, et al. Colorectal liver metastases that survive radioembolization display features of aggressive tumor behavior. HPB. 2023. doi:10.1016/j.hpb.2023.06.011
BibTeX
@article{Andel2023,
author = {Andel, Daan and Hagendoorn, Jeroen and Alsultan, Ahmed Aziz and Lacle, Miangela Marie and Smits, Maarten Leonard Johannes and Braat, Arthur Johannes Anthonius Theodorus and Kranenburg, Onno and Lam, Marnix Gerard Ernest Hendrik and Borel Rinkes, Inne Hilbrand Max},
title = {Colorectal liver metastases that survive radioembolization display features of aggressive tumor behavior},
journal = {HPB},
year = {2023},
doi = {10.1016/j.hpb.2023.06.011}
}
EUVIMED